<DOC>
	<DOCNO>NCT02789540</DOCNO>
	<brief_summary>This multi-country , multicentre , observational prospective data collection cross sectional study patient stable COPD Latin America . Primary objective ass characterize COPD symptoms period 24 hour , collect information respiratory symptom experience different time day night-time patient stable COPD real clinical practice condition . Correlation symptom Global Initiative Chronic Obstructive Lung Disease ( GOLD ) classification , adherence respiratory treatment , level dyspnea , disease severity , comorbidities physical activity well direct cost do secondary objective . Study population patient 40 year old , smoker ex smoker &gt; = 10 pack/years previous COPD diagnosis , attend outpatient specialist consult Argentina , Chile , Colombia , Uruguay , Costa Rica , Guatemala Mexico . Sample size target 900 enroled patient order ensure 860 patient achieve statistical power primary objective .</brief_summary>
	<brief_title>Latin American Study 24-hs Symptoms Chronic Obstructive Pulmonary Disease ( COPD ) Patients ; LASSYC Study</brief_title>
	<detailed_description>This multi-country , multicentre , observational prospective data collection cross sectional study patient stable COPD Latin America . Primary objective describe prevalence , severity interrelationship early morning , day night-time symptom patient stable COPD Latin America ( LatAm ) . Secondary objective evaluate relationship early morning , day night-time symptoms 2013 GOLD classification , adherence respiratory treatment ( TAI Morisky Medicaction Adherence Scale - MMAS-8 ) , level dyspnea ( mMRC ) , disease severity ( BODEX ) , comorbidities ( COTE ) physical activity ( IPAQ ) well direct cost assess health resource utilization ( HRU ) exacerbation last 12 month respiratory treatment last 2 month . Study population patient 40 year old , smoker ex smoker &gt; = 10 pack/years previous COPD diagnosis , attend outpatient specialist consult Argentina , Chile , Colombia , Uruguay , Costa Rica , Guatemala Mexico . Sample size target 900 enroled patient order ensure 860 patient achieve statistical power primary objective . Data source study conduct : site staff retrospectively collect necessary information patient 's medical record determine eligibility . Consecutively , patient diagnosis stable COPD screen , eligible , consent enrol . There one study visit . For patient , physician collect follow data visit ( medical record interview study visit ) : social demographic , health insurance system , lifestyle , smoke history , comorbidities , level dyspnea , disease severity , COPD prescribe treatment include therapeutic class , device , modality ( rescue/maintenance ) posology last past 2 month , exacerbation history healthcare resource utilisation last 12 month . In addition , patient ask provide data disease-related symptomatology assess 24 hs day ( early morning , daytime night time symptom ) , adherence inhaler , health-related quality life ( HRQoL ) physical activity . AstraZeneca develop Data Management Plan ( DMP ) website database platform purpose study . Data register PI directly website data platform . The LASSYC study observational cross sectional study involve study specific medicinal product . Because non-interventional nature study , simple monitoring plan require . 100 % source data verification ( SDV ) 10 % total enrolled patient , estimate one site per country would enough.The Non-Interventional Study perform accordance ethical principle consistent Declaration Helsinki , International Conference Harmonization ( ICH ) Good Clinical Practice ( GCP ) applicable legislation Non-Interventional Studies .</detailed_description>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>Male female patient age 40 year old . Patient diagnosis COPD 1 year . Patient least one spirometry COPD criterion , fix ratio &lt; 0.70 post bronchodilator ( BD ) , previous 12 month Patient current smoker exsmoker smoke history â‰¥ 10 packyears . Stable patient , state medical record patient report visit , define : without exacerbation treatment study visit neither previous 2 month , without change maintenance COPD treatment regimen precede 2 month ( avoid first consult patient ) Patients must able willing read comprehend write instruction , comprehend complete questionnaire require protocol After full explanation , patient must sign informed consent document indicate understand purpose procedure require study willing participate study . Exclusion Criteria Patient diagnosis sleep apnea syndrome chronic respiratory disease different chronic obstructive disease . An acute chronic condition , investigator 's opinion , would limit patient 's ability complete questionnaire participate study</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>COPD symptom</keyword>
</DOC>